We are live on ! Find out more
EM

Excalibur Management Portfolio holdings

AUM $278M
1-Year Est. Return 20.09%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+20.09%
3 Year Est. Return
+68.93%
5 Year Est. Return
+93.63%
10 Year Est. Return
+240.99%
AUM
$118M
AUM Growth
+$6.11M
Cap. Flow
+$2.23M
Cap. Flow %
1.89%
Top 10 Hldgs %
51.23%
Holding
80
New
10
Increased
20
Reduced
26
Closed
2

Top Buys

Rank Stock Value
1
CSL icon
Carlisle Companies
CSL
+$1.39M
2
CPB icon
Campbell Soup
CPB
+$477K
3
QCOM icon
Qualcomm
QCOM
+$434K
4
WFC icon
Wells Fargo
WFC
+$370K
5
GIS icon
General Mills
GIS
+$343K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$416K
2
INTC icon
Intel
INTC
+$312K
3
KO icon
Coca-Cola
KO
+$295K
4
PG icon
Procter & Gamble
PG
+$289K
5
DD
Du Pont De Nemours E I
DD
+$236K

Sector Composition

Rank Sector Weight
1 Healthcare 21.22%
2 Industrials 15.51%
3 Financials 14.47%
4 Communication Services 13.68%
5 Technology 11.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSL icon
1
Carlisle Companies
CSL
$14.1B
$9.94M 8.44%
99,095
+14,346
+17% +$1.39M
T icon
2
AT&T
T
$169B
$7.49M 6.36%
253,034
+8,070
+3% +$229K
VZ icon
3
Verizon
VZ
$201B
$7.09M 6.03%
143,367
+2,580
+2% +$121K
JNJ icon
4
Johnson & Johnson
JNJ
$643B
$6.64M 5.65%
51,109
+670
+1% +$88.8K
PFE icon
5
Pfizer
PFE
$144B
$6.29M 5.35%
185,772
-3,968
-2% -$128K
MRK icon
6
Merck
MRK
$326B
$5.18M 4.4%
84,782
-6,859
-7% -$416K
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.11T
$4.62M 3.92%
25,176
-620
-2% -$110K
JPM icon
8
JPMorgan Chase
JPM
$950B
$4.55M 3.86%
47,632
-365
-0.8% -$33.7K
GE icon
9
GE Aerospace
GE
$377B
$4.49M 3.81%
38,726
+627
+2% +$75.8K
MSFT icon
10
Microsoft
MSFT
$2.92T
$4.01M 3.41%
53,847
-3,150
-6% -$230K
XOM icon
11
ExxonMobil
XOM
$634B
$3.95M 3.35%
48,146
+685
+1% +$54.4K
AAPL icon
12
Apple
AAPL
$4.99T
$3.9M 3.31%
101,132
+140
+0.1% +$5.43K
PG icon
13
Procter & Gamble
PG
$347B
$3.57M 3.03%
39,198
-3,175
-7% -$289K
PEP icon
14
PepsiCo
PEP
$195B
$2.62M 2.22%
23,496
-986
-4% -$114K
KO icon
15
Coca-Cola
KO
$380B
$2.58M 2.19%
57,329
-6,486
-10% -$295K
IBM icon
16
IBM
IBM
$214B
$2.11M 1.79%
15,210
+983
+7% +$137K
GILD icon
17
Gilead Sciences
GILD
$167B
$1.87M 1.59%
23,127
+240
+1% +$18.4K
CVX icon
18
Chevron
CVX
$374B
$1.83M 1.56%
15,612
-240
-2% -$26.2K
INDB icon
19
Independent Bank
INDB
$4.1B
$1.78M 1.52%
23,917
SPY icon
20
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$1.66M 1.41%
6,596
+29
+0.4% +$7.15K
RTX icon
21
RTX Corp
RTX
$295B
$1.42M 1.21%
19,462
+135
+0.7% +$9.99K
PM icon
22
Philip Morris
PM
$312B
$1.39M 1.18%
12,551
+60
+0.5% +$6.98K
CSCO icon
23
Cisco
CSCO
$456B
$1.24M 1.05%
36,785
+1,200
+3% +$38.2K
AMGN icon
24
Amgen
AMGN
$212B
$1.23M 1.05%
6,605
ABT icon
25
Abbott
ABT
$187B
$1.21M 1.03%
22,740
-1,450
-6% -$72.8K

Similar funds

Excalibur Management's Q3 2017 Portfolio in Review

As of Q3 2017, Excalibur Management held 80 positions worth $118M, up 5.5% from $112M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Excalibur Management's Q3 2017 filing shows 10 new, 20 increased, 26 reduced and 2 closed positions. Its largest new stake was Campbell Soup: 9,409 shares worth $441K. The largest sale was Merck, an estimated $416K.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Financials.

  • Excalibur Management's largest Q3 2017 buy was Campbell Soup: 9,409 shares worth $441K.
  • Excalibur Management added most to Carlisle Companies in Q3 2017, an estimated $1.39M increase.
  • Excalibur Management's biggest Q3 2017 reduction was Merck, cutting an estimated $416K.
  • Excalibur Management fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $236K.
  • Excalibur Management's ten largest holdings make up 51% of its $118M portfolio in Q3 2017.
  • Excalibur Management opened 10 new positions and closed 2 in Q3 2017.
  • Excalibur Management's portfolio value rose 5.5% quarter-over-quarter to $118M.

Based on Excalibur Management's 13F filing for Q3 2017, filed 25 Oct 2017.